IMGLOTUMIO Trademark

Trademark Overview

On Wednesday, May 12, 2021, a trademark application was filed for IMGLOTUMIO with the United States Patent and Trademark Office. The USPTO has given the IMGLOTUMIO trademark a serial number of 90706360. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Friday, May 24, 2024. This trademark is owned by Genentech, Inc.. The IMGLOTUMIO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in oncology
imglotumio

General Information

Serial Number90706360
Word MarkIMGLOTUMIO
Filing DateWednesday, May 12, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateFriday, May 24, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 5, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in oncology

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 11, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGenentech, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameGenentech, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Saturday, May 15, 2021NEW APPLICATION ENTERED
Wednesday, August 11, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 27, 2021ASSIGNED TO EXAMINER
Friday, August 27, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 15, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 5, 2021PUBLISHED FOR OPPOSITION
Tuesday, October 5, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 30, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 24, 2022SOU EXTENSION 1 GRANTED
Tuesday, May 24, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, May 24, 2022SOU EXTENSION 1 FILED
Thursday, May 26, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 25, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, August 25, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 25, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, August 25, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, April 19, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, October 26, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, October 26, 2022SOU EXTENSION 2 FILED
Wednesday, October 26, 2022SOU EXTENSION 2 GRANTED
Friday, October 28, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 18, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 19, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, April 19, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, April 19, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 16, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, May 16, 2023SOU EXTENSION 3 FILED
Tuesday, May 16, 2023SOU EXTENSION 3 GRANTED
Friday, November 10, 2023SOU EXTENSION 4 GRANTED
Friday, November 10, 2023SOU TEAS EXTENSION RECEIVED
Friday, November 10, 2023SOU EXTENSION 4 FILED
Friday, May 24, 2024SOU TEAS EXTENSION RECEIVED
Friday, May 24, 2024SOU EXTENSION 5 FILED
Friday, May 24, 2024SOU EXTENSION 5 GRANTED
Tuesday, November 14, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

imglotumio oncology preparations pharmaceutical